Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Suha A. Tashkandi"'
Autor:
Ragdah M. Alamri, Maryam Alanazi, Rajeh K. AlRajeh, Suha A. Tashkandi, Azizah F. Alswayyed, Manar A. Samman, Abdul Ali Peer‐Zada
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key Clinical Message In a patient with de novo AML, co‐existing BCR::ABL1 p190 isoform and RUNX1::MECOM rearrangement is accompanied by a very poor prognosis including limited response to treatment and no molecular remission. It is essential to dev
Externí odkaz:
https://doaj.org/article/1967d03d5fd04e0da8dafa69ca3368a6
Autor:
Mohammed A. Bafail, Rahaf AlTahan, Manar A. Samman, Suha A. Tashkandi, Ibraheem H. Motabi, Abdul Ali Peer‐Zada
Publikováno v:
Clinical Case Reports, Vol 11, Iss 7, Pp n/a-n/a (2023)
Key Clinical Message Complete molecular remission in a “variant APL” patient with short isoform of PML‐RARα and FLT3‐ITD mutation was achieved in response to ATRA and ATO plus IDA instead of standard treatment protocol. The use of FLT3 inhib
Externí odkaz:
https://doaj.org/article/3d850dd1ae6c43448c3ca23808964ac4
Autor:
Mofareh AlZahrani, Eman AlIdrissi, Hamza Ali Alghamdi, Suha A. Tashkandi, Enas S. Alharbi, Murad K. Habazi, Khelad A. AlSaidi, Rawan D. Aledielah
Publikováno v:
Journal of Clinical Immunology. 38:847-853
Autor:
Suha A. Tashkandi, Musa Al Harbi, Nahla Ali Mobark, Khalid Al Saidi, Zaheer Ullah, Wafa Al Shakweer, Othman Mosleh, Suha A. Fataftah, Fahad El Manjomi, Awatif Alanazi, Mohammed Rayis, Mohammed M. Al Nemer, Walid Ballourah
Publikováno v:
Journal of Cancer Therapy. :299-314
Background: Non-Hodgkin’s lymphoma is an aggressive malignant disease in children and adolescents. Although it is the fourth most common malignancy in Saudi children as reported in Saudi cancer registry, less information is available about pediatri